Excess adiposity is thought to impact on the cancer microenvironment and increase production of leptin, plasminogen activator inhibitor and endothelial growth factor, reduced adiponectin, insulin resistance and inflammation [36]. The gene discussed is ADIPOQ; the disease is Insulin resistance.